Reimagining the Future of Clinical Trials
summary
Panel lays out concrete bottlenecks and fixes: fragmented systems with 3.6 million data points per trial and EDC setup taking 68.3 days, real examples of IRT failures (Fortrea-Acceleron) that misdosed patients, and regulatory friction as FDA promises a spring AI guidance while EMA issues AI reflections. Concrete solutions include EHR-to-cloud integration, AI for disease prediction and safety monitoring, decentralized digitized PROs (Apple Watch–style), and using real‑world evidence for approvals — decide based on interest in implementation details, risks, and regulatory realities.
AI-written summary · about
chapters (8)
- 0:00Introduction to the panel
- 1:00Current challenges in trials
- 5:28Technical fragmentation
- 8:16Innovative trial approaches
- 14:59The role of AI in trials
- 21:22Bridging research and care
- 29:33Automation and quality
- 32:24Future visions and wrap-up
related talks
13mAI-Powered Clinical Trials
52mPanel: AI-Enhanced Healthcare: Future Trends
19mThe future of AI in powering clinical trial innovation
59mKeynote Panel AI in Healthcare
50mA Sustainable Future for Learning AI in Healthcare
35mUsing Large-Scale Clinico-Genomics Data for in silico Clinical Trials and Precision Oncology
01h 00mKeynote Panel: AI in Healthcare
20mInnovating Clinical Research with AI and Real World Data